What is the current Price Target for the Summit Therapeutics PLC Sponsored ADR stock?

The average Summit Therapeutics PLC Sponsored ADR target price is $35.44. This is 104.65% higher than the current stock price. The highest price target is 154.04%, the lowest is 73.21%. 9 Analysts have issued a price target Summit Therapeutics PLC Sponsored ADR 2026 .

How high will the Summit Therapeutics PLC Sponsored ADR stock rise?

No reliable answer can be given as to how high the Summit Therapeutics PLC Sponsored ADR stock will rise. The performance of stocks, including the Summit Therapeutics PLC Sponsored ADR stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Summit Therapeutics PLC Sponsored ADR stock today?

The performance of Summit Therapeutics PLC Sponsored ADR stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Summit Therapeutics PLC Sponsored ADR stock fall?

The decline in Summit Therapeutics PLC Sponsored ADR stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Summit Therapeutics PLC Sponsored ADR Forecast, price target & analysts

$17.32

0.23% yesterday

Nasdaq, Apr 07, 10:08 pm CET

ISIN

US86627R1023

Symbol

SMMT

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Summit Therapeutics PLC Sponsored ADR Target price 2025 - Analyst rating & recommendation

Summit Therapeutics PLC Sponsored ADR Classifications & Recommendation:

Buy

100%

Summit Therapeutics PLC Sponsored ADR Price Target

Target Price	$35.44
Price	$17.32
Potential	104.65% register free of charge
Number of Estimates	9

	9 Analysts have issued a price target Summit Therapeutics PLC Sponsored ADR 2026 . The average Summit Therapeutics PLC Sponsored ADR target price is $35.44. This is 104.65% register free of charge higher than the current stock price. The highest price target is $44.00 154.04% register free of charge , the lowest is $30.00 73.21% register free of charge .
	A rating was issued by 10 analysts: 10 Analysts recommend Summit Therapeutics PLC Sponsored ADR to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Summit Therapeutics PLC Sponsored ADR stock has an average upside potential 2026 of 104.65% register free of charge . Most analysts recommend the Summit Therapeutics PLC Sponsored ADR stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-0.31	-0.43
	68.69%	38.71%
P/E		negative

3 Analysts have issued a Summit Therapeutics PLC Sponsored ADR forecast for earnings per share. The average Summit Therapeutics PLC Sponsored ADR EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-0.31	68.69%
2025	$-0.43 38.71% Unlock
2026	$-0.59 37.21% Unlock
2027	$-0.55 6.78% Unlock
2028	$0.51 192.73% Unlock
2029	$1.64 221.57% Unlock

Current	-56.31	2,134.52%
2025	-40.59 27.92% Unlock
2026	-29.19 28.09% Unlock
2027	-31.68 8.53% Unlock
2028	34.30 208.27% Unlock
2029	10.56 69.21% Unlock

Summit Therapeutics PLC Sponsored ADR...

Current Summit Therapeutics PLC Sponsored ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Citigroup	Locked ➜ Locked	Locked	Mar 26 2025
Cantor Fitzgerald	Locked ➜ Locked	Locked	Mar 21 2025
Evercore ISI Group	Locked ➜ Locked	Locked	Mar 12 2025
Goldman Sachs	Locked ➜ Locked	Locked	Feb 28 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 25 2025
Citizens Capital Markets	Locked ➜ Locked	Locked	Feb 25 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 21 2025

Analyst Rating	Date
Locked Citigroup: Locked ➜ Locked	Mar 26 2025
Locked Cantor Fitzgerald: Locked ➜ Locked	Mar 21 2025
Locked Evercore ISI Group: Locked ➜ Locked	Mar 12 2025
Locked Goldman Sachs: Locked ➜ Locked	Feb 28 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 25 2025
Locked Citizens Capital Markets: Locked ➜ Locked	Feb 25 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 21 2025

Discover more stocks with a high price target

MongoDB 96.77%

Coinbase Global, Inc. 95.22%

BioNTech SE - ADR 59.48%

Snowflake 58.39%

Alibaba Group Holding Ltd 58.36%

PayPal 58.24%

NIO ADR 57.59%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now